Found: 55
Select item for more details and to access through your institution.
A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 4, p. 386, doi. 10.1007/s10637-024-01448-w
- By:
- Publication type:
- Article
Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma.
- Published in:
- American Journal of Cancer Research, 2024, v. 14, n. 6, p. 2905, doi. 10.62347/LLXR8002
- By:
- Publication type:
- Article
Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 239, doi. 10.1007/s40487-024-00272-9
- By:
- Publication type:
- Article
Diagnostic Accuracy in Detecting Fungal Infection with Ultra-Low-Dose Computed Tomography (ULD-CT) Using Filtered Back Projection (FBP) Technique in Immunocompromised Patients.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1704, doi. 10.3390/jcm13061704
- By:
- Publication type:
- Article
Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 2, p. 105, doi. 10.1016/j.clml.2023.09.007
- By:
- Publication type:
- Article
Very late relapse in Hodgkin lymphoma: Characterizing an understudied population.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 838, doi. 10.1016/j.clml.2023.07.012
- By:
- Publication type:
- Article
Mosunetuzumab Monotherapy Demonstrates Durable Efficacy and Manageable Safety in Patients With Relapsed/Refractory Follicular Lymphoma and =2 Prior Therapies: Updated Results From a Pivotal Phase 2 Study.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 359
- By:
- Publication type:
- Article
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
- Published in:
- Current Oncology, 2023, v. 30, n. 7, p. 6166, doi. 10.3390/curroncol30070458
- By:
- Publication type:
- Article
Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada.
- Published in:
- Current Oncology, 2023, v. 30, n. 5, p. 4663, doi. 10.3390/curroncol30050352
- By:
- Publication type:
- Article
Nuclear Export in Non-Hodgkin Lymphoma and Implications for Targeted XPO1 Inhibitors.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 1, p. 111, doi. 10.3390/biom13010111
- By:
- Publication type:
- Article
Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1538, doi. 10.1002/ajh.26726
- By:
- Publication type:
- Article
Tumor Infiltrating Lymphocytes Predict Survival in Solid Organ Transplant Recipients With Monomorphic Post-transplant Lymphoproliferative Disorders.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. 744, doi. 10.1016/j.clml.2022.05.006
- By:
- Publication type:
- Article
Predicting the Risks of Aggressive-Intent Chemotherapy Toxicity in Older Patients With Lymphoma: A Prospective Observational Pilot Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e792, doi. 10.1016/j.clml.2022.04.011
- By:
- Publication type:
- Article
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 483, doi. 10.1016/j.clml.2021.12.016
- By:
- Publication type:
- Article
Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 583, doi. 10.1002/ajh.26500
- By:
- Publication type:
- Article
Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 394, doi. 10.1002/jha2.394
- By:
- Publication type:
- Article
Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00268-z
- By:
- Publication type:
- Article
Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma.
- Published in:
- EJHaem, 2022, v. 3, n. 1, p. 223, doi. 10.1002/jha2.286
- By:
- Publication type:
- Article
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 24, doi. 10.1016/j.clml.2021.07.017
- By:
- Publication type:
- Article
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 388, doi. 10.1111/bjh.17673
- By:
- Publication type:
- Article
Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01144-9
- By:
- Publication type:
- Article
Poster: HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S237, doi. 10.1016/S2152-2650(21)01489-0
- By:
- Publication type:
- Article
HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S373, doi. 10.1016/S2152-2650(21)01854-1
- By:
- Publication type:
- Article
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Gelatin‐Hyaluronan Click‐Crosslinked Cryogels Elucidate Human Macrophage Invasion Behavior.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 28, p. 1, doi. 10.1002/adfm.202008400
- By:
- Publication type:
- Article
Human Macrophage Invasion: Gelatin‐Hyaluronan Click‐Crosslinked Cryogels Elucidate Human Macrophage Invasion Behavior (Adv. Funct. Mater. 28/2021).
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 28, p. 1, doi. 10.1002/adfm.202170205
- By:
- Publication type:
- Article
Computerized cognitive training in post-treatment hematological cancer survivors: a feasibility study.
- Published in:
- Pilot & Feasibility Studies, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40814-021-00778-3
- By:
- Publication type:
- Article
Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 1, p. e28, doi. 10.1111/bjh.17177
- By:
- Publication type:
- Article
Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 864, doi. 10.1111/bjh.16777
- By:
- Publication type:
- Article
Radiotherapy in mantle cell lymphoma: A literature review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 1, p. 97, doi. 10.1111/bjh.16304
- By:
- Publication type:
- Article
Resources-Stratified Guidelines for Classical Hodgkin Lymphoma.
- Published in:
- International Journal of Environmental Research & Public Health, 2020, v. 17, n. 5, p. 1783, doi. 10.3390/ijerph17051783
- By:
- Publication type:
- Article
Nivolumab Combined with Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL): Efficacy and Safety Results from the Phase 2 CheckMate 436 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S303, doi. 10.1016/j.clml.2019.07.262
- By:
- Publication type:
- Article
Axicabtagene Ciloleucel (Axi-Cel) versus Standard-of-Care Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma: ZUMA-7, A Phase 3, Randomized Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S293, doi. 10.1016/j.clml.2018.07.238
- By:
- Publication type:
- Article
You have free access to this contentBrentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 5, p. 757, doi. 10.1111/bjh.14449
- By:
- Publication type:
- Article
Impact of comorbidities constituting the hematopoietic cell transplant (HCT)‐comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 2, p. 198, doi. 10.1111/ejh.13000
- By:
- Publication type:
- Article
Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma.
- Published in:
- Drugs, 2017, v. 77, n. 15, p. 1645, doi. 10.1007/s40265-017-0796-z
- By:
- Publication type:
- Article
SCHOLAR-1 versus ZUMA-1: A Standardized Comparison of Outcomes in Patients (Pts) with Refractory, Aggressive Non-Hodgkin Lymphoma (rNHL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S362, doi. 10.1016/j.clml.2017.07.197
- By:
- Publication type:
- Article
Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 3, p. 234, doi. 10.1111/ejh.12909
- By:
- Publication type:
- Article
Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Gamma Delta T Cell Subset V Gamma 2+ Expansion Associated with Longterm Infliximab Treatment in a Patient with Ankylosing Spondylitis.
- Published in:
- 2016
- By:
- Publication type:
- case study
Outcomes in Refractory Aggressive Diffuse Large B Cell Lymphoma (DLBCL): Results from the International SCHOLAR-1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S101, doi. 10.1016/j.clml.2016.07.147
- By:
- Publication type:
- Article
Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 3, p. 384, doi. 10.1111/bjh.13451
- By:
- Publication type:
- Article
Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 5, p. 392, doi. 10.1002/ajh.23955
- By:
- Publication type:
- Article
Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 4, p. 273, doi. 10.1111/ejh.12338
- By:
- Publication type:
- Article
A Comparison of Long-Term Outcomes of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors in Patients With Relapsed CML After Allogeneic Hematopoietic Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2014, v. 14, n. 1, p. 87, doi. 10.1016/j.clml.2013.09.010
- By:
- Publication type:
- Article
Phase IA/ II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non- Hodgkin or Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 2, p. 258, doi. 10.1111/bjh.12630
- By:
- Publication type:
- Article
Limited benefit of pentostatin salvage therapy for steroid-refractory grade III- IV acute graft-versus-host disease.
- Published in:
- Clinical Transplantation, 2013, v. 27, n. 6, p. 930, doi. 10.1111/ctr.12268
- By:
- Publication type:
- Article